You are invited to hear Jonathan Henderson, MD, Lawrence Karsh, MD, and Gordon A. Brown, DO, discuss Erleada for the treatment of advanced prostate cancer (mCSPC and nmCRPC). The live presentations will be held three times on Thursday, January 21, 2021 and will not be available on demand later.


LUGPA and Janssen present: 
Erleada: TITAN and New Data for SPARTAN Final Analysis


SAVE THE DATE : January 21, 2021 


12:15 PM ET – Gordon Brown, DO, FACOS
Medical Director, New Jersey Urology, Sewell, NJ
https://zoom.us/meeting/register/tJYoduqurTMjH9Fneb_xUxHBzsyliXSPH49d


12:15 PM CT – R. Jonathan Henderson, MD
 CEO, Assistant Director of Clinical Research Regional Urology, LLC, Shreveport, LA
https://zoom.us/meeting/register/tJckcO2pqz0uHN0AAS5ozqQlfos66f7hISTv


12:15 PM PT – Lawrence Karsh, MD
Director of Research/ Attending Urologist The Urology Center of Colorado, Denver, CO
https://zoom.us/meeting/register/tJwuceCtpj4vGtX4mRvXaazcdrH8AiS3WBC-


Please use the URLs above to register for the broadcast in advance and to access the broadcast.


See full Prescribing Information.

SPEAKERS

     

Jonathan Henderson, MD
President, LUGPA
Chief Executive Officer, Regional Urology
Shreveport, LA

Dr. Henderson earned a Bachelor of Science Degree at LSU in Baton Rouge in microbiology. After receiving his M.D. at LSU Medical Center in Shreveport, he completed his internship and residency in Urology at LSUMC Hospital. Dr. Henderson spent the next six years in practice in Alabama where he pioneered urologic laparoscopy.

In 2002, Dr. Henderson was asked to return to Shreveport to join the nascent Regional Urology. Currently, he serves Regional Urology as Chief Executive Officer.

Dr. Henderson is certified by the American Board of Urology. He is a member of the American Urologic Association (and sits on many committees for that organization), Shreveport Medical Society, Louisiana State Medical Society, and the Alpha Omega Alpha Medical Honor Society.  He has been on the LUGPA Board of Directors since 2011 and is currently serving as President.

     

Gordon A. Brown, DO
New Jersey Urology, LLC
Moorestown, NJ
 
Board certified by the American Osteopathic Association, Dr. Gordon Brown completed a uro-logic oncology fellowship at the UTMD Anderson Cancer Center in Houston, TX.  He special-izes in the treatment of prostate cancer and serves as Director of Delaware Valley Urology’s Center for Advanced Therapeutics and Program Director of Urologic Surgery at Rowan Univer-sity School of Osteopathic Medicine.

Dr. Brown has been practicing urology over ten years.

     

Lawrence Karsh, MD, FACS
Co-founder, The Urology Center of Colorado
Denver, CO

Dr. Karsh is a Certified Principal Investigator and the primary investigator of research studies at TUCC. He graduated from the Chicago Medical School and completed his General Surgical training at The University of Colorado Health Sciences Center under Dr. Thomas Starzl. He completed his Urology residency at Brigham and Women’s Hospital/Harvard Medical School under Dr. Ruben Gittes. He is a co-founder of The Urology Center of Colorado where he serves as an attending Urologist, Director of Research & Co-Chairman of Advanced Therapeutic Clin-ic. He has been the principle investigator for over 250 clinical trials.

Dr. Karsh has authored a number of peer-reviewed publications and serves on the editorial boards for Oncology Live, Urologist and Cancer Care, and Bladder Cancer. He is a fellow of the American College of Surgeons, and an active member AUA, SUO, ASCO, SWOG, ACS, and the Denver Academy of Surgeons. He served on the bladder cancer subcommittee and the advi-sory board for the SUO Clinical Trials Consortium from 2010-2020. He is a member of the Bladder Cancer Advocacy Network (BCAN) Think Tank.

Dr. Karsh completed his General Surgery training at The University of Colorado Health Scienc-es Center (UCHSC) and his Urology residency at Brigham and Women’s Hospital/Harvard Medical School. He is an associate clinical professor of surgery at UCHSC. Dr. Karsh serves as an advisor and consultant to the pharmaceutical industry, participating in drug development and research protocols. He educates physicians about newly approved therapies and he teaches at scientific meetings throughout the country.

In his spare time, Dr. Karsh is an avid road bicycler and skier.

  

 


In adherence with PhRMA guidelines, spouses or other guests are not permitted to attend company-sponsored programs. For all attendees, please be advised that information such as your name and the value and purpose of any educational item, meal, or other items of value you receive may be publicly disclosed. If you are licensed in any state or other jurisdiction, or are an employee or contractor of any organization or governmental entity, that limits or prohibits meals from pharmaceutical companies, please identify yourself so that you (and we) are able to comply with such requirements. Please note that the company prohibits the offering of gifts, gratuities, or meals to federal government employees/officials. Thank you for your cooperation. 

This promotional educational activity is not accredited. The program content is developed by Janssen Biotech, Inc. Speakers present on behalf of the company and are required to present information in compliance with FDA requirements for communications about its medicines. The personal information you provide may be used to contact you about your request to attend the Janssen Biotech, Inc., educational program using your preferred method of communication as indicated by you. This information may be shared with Janssen Biotech, Inc., its affiliates, and a third party for the sole purpose of completing your registration for this program and as required by law.